# Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy

Source: https://onco.cc/trials/nct06268327/  
OnCo record `nct06268327` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial of cisplatin, gemcitabine and capecitabine in triple-negative breast cancer, run by Assiut University, not yet recruiting.

## Summary

Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy is a phase 2/3, randomised interventional study registered as NCT06268327 by Assiut University, with a registry enrolment figure of 30 participants, started 2024-04-30 and due to reach its primary completion in 2025-10-30. Interventions recorded: Cisplatin injection and gemcitabine; Capecitabine tablets. Conditions listed: Breast Cancer. Triple-negative eligibility wording from the registry: "* Tumor subtype: triple negative". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT06268327
- Phase: 2/3
- Setting: Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy
- Sponsor: Assiut University
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT06268327: https://clinicaltrials.gov/study/NCT06268327

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06268327.json